Condition: Sickle Cell Disease · Sponsor: Emory University
The purpose of this study is to determine whether giving extra arginine to patients with sickle cell disease seeking treatment for vaso-occlusive painful events (VOE) will decrease pain scores, decrease need for pain medications or decrease length of hospital stay or emergency department visit.
This description comes directly from the study's public registry record.
Reshika Mendis, MBBS · 404-785-4525 · Reshika.mendis@choa.org
Claudia Morris, MD · 404 727-5500 · claudia.r.morris@emory.edu
Always discuss trial participation with your own doctor first.
| Children's Healthcare fo Atlanta at Hughes Spalding | Atlanta, Georgia, United States | Recruiting |
| Children's Healthcare of Atlanta at Arthur M. Blank Hospital | Atlanta, Georgia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02447874